Vera Therapeutics, Inc.
VERA
$39.96
-$1.21-2.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -91.10M | -80.29M | -76.53M | -51.69M | -43.43M |
| Total Depreciation and Amortization | 135.00K | 129.00K | 119.00K | 85.00K | 55.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.61M | 9.57M | 8.23M | 6.64M | 4.92M |
| Change in Net Operating Assets | 10.36M | 8.69M | 13.38M | -9.44M | -728.00K |
| Cash from Operations | -69.99M | -61.91M | -54.80M | -54.41M | -39.18M |
| Capital Expenditure | -102.00K | -133.00K | -208.00K | -187.00K | -645.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80.77M | 69.89M | 28.75M | 15.50M | -220.74M |
| Cash from Investing | 80.66M | 69.76M | 28.54M | 15.32M | -221.38M |
| Total Debt Issued | 0.00 | 0.00 | 23.34M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 304.19M | 797.00K | 464.00K | 1.53M | 347.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.91M | 0.00 | -3.52M | -- | -21.36M |
| Cash from Financing | 286.28M | 797.00K | 20.29M | 1.53M | 325.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 296.95M | 8.65M | -5.97M | -37.56M | 65.39M |